Medical Research Commercialisation Fund

Program Overview

The Medical Research Commercialisation Fund (MRCF) is a strategic initiative under the Australian Government’s Medical Research Future Fund (MRFF), designed to accelerate the translation of early-stage health and medical research into commercial outcomes. Its primary objective is to support innovative medical research and technologies through proof-of-concept and beyond, thereby increasing the likelihood of successful commercialisation and attracting further private investment.

With a total allocation of $311.3 million over 10 years, the MRCF focuses on bridging the gap between laboratory discoveries and market-ready medical innovations. The Fund supports projects across multiple streams, including preclinical research, early clinical development of novel drugs and medical devices, and digital health technologies, aiming to improve health outcomes and build a sustainable health economy in Australia.

Key Details

• Funding amount or range:
  • Grants up to $1 million per project for early-stage medical research and innovation
  • Total funding of $311.3 million allocated over 10 years under the Medical Research Commercialisation Initiative
• Application open and close dates:
  • Applications are generally open on an ongoing or periodic basis, depending on specific grant rounds (check current calls for exact dates)
  • Past rounds, such as the 2020 Early Stage Translation and Commercialisation Support Grant, have closed; new rounds are announced periodically
• Eligible industries and business types:
  • Medical research institutes, universities, corporate Commonwealth entities, corporations (including SMEs and not-for-profits)
  • Partnerships are encouraged, with a lead organisation driving the project
• Co-contribution or matching fund requirements:
  • Applicants must demonstrate the capacity to meet project costs not covered by grant funding, including evidence of board or CEO support
  • Matching funds are not explicitly required, but financial sustainability and co-investment strengthen applications
• Location/state/territory applicability:
  • Projects must be conducted in Australia and benefit the Australian health and medical research sector

Eligibility Criteria

• Must have an Australian Business Number (ABN) and be incorporated in Australia
• Be one of the following entities: medical research institute, university, corporate Commonwealth entity, or corporation (including not-for-profits)
• Individuals, partnerships, unincorporated associations, trusts (unless incorporated trustee), and non-corporate Commonwealth entities are ineligible
• Provide evidence of project support from governing bodies (board or CEO) and letters of support from project partners
• Nominate a Project Manager responsible for project delivery and reporting
• Submit only one application per funding stream, with a maximum of two funded streams per organisation

Eligible Activities and Expenses

• Preclinical medical research or medical innovation projects with commercial potential
• Early clinical development of novel drugs or new uses for existing drugs
• Early clinical development of medical devices addressing unmet clinical needs
• Early-stage development of digital health technologies with commercial potential
• Activities that progress projects to proof-of-concept and de-risk them for private investment
• Eligible expenses include research costs, development activities, project management, and associated operational costs directly related to the project

Assessment Process

• The grant is competitive and assessed by an independent committee of experts
• Applications are first screened for eligibility before a detailed evaluation
• Assessment criteria and weighting:
  • Project impact (40%)
  • Project methodology (30%)
  • Capacity, capability, and resources to deliver the project (30%)
  • Overall value and risk of the project (non-weighted)
• Final funding decisions are made by the program delegate based on committee recommendations
• Successful applicants enter into a grant agreement specifying milestones, reporting, and payment schedules

Application Tips

• Clearly specify the funding stream applicable to your project and align your proposal accordingly.
• Provide robust evidence of commercial potential and how the project addresses unmet clinical needs.
• Demonstrate organisational capacity, including experienced project management and resource availability.
• Include letters of support from partners and governing bodies to strengthen credibility.
• Detail project methodology and expected impact with measurable outcomes.
• Ensure compliance with application guidelines and submit all required documentation before deadlines.

Further Support

Engaging professional grant advisors like Pattens Group can significantly enhance your application’s quality and compliance. With over 30 years of experience assisting Australian businesses to secure grants, Pattens offers expert guidance in navigating complex eligibility criteria, preparing compelling applications, and managing grant administration. Consulting with seasoned professionals ensures your project aligns strategically with funding objectives and maximises the likelihood of success. Contact us to leverage our expertise and advance your medical research commercialisation goals.